A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

NCT07545772 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome
Constipation

Interventions

DRUG: LY3537031
DRUG: Placebo

Sponsor

Eli Lilly and Company